GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 25 filers reported holding GAIN THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.73 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 90,000 | $403 | 0.39% |
| Greenlight Capital | 546,560 | $2,448,589 | 0.12% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 58,100 | $260,288 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 46,100 | $206,528 | 0.01% |
| Tower Research Capital LLC (TRC) | 4,347 | $19,475 | 0.00% |
| NewEdge Advisors, LLC | 11,050 | $49,504 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| HM PAYSON & CO | 1,000 | $4,480 | 0.00% |
| GROUP ONE TRADING, L.P. | 847 | $3,795 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 138,721 | $621,470 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 12,562 | $56,278 | 0.00% |
| MORGAN STANLEY | 800 | $3,584 | 0.00% |
| BlackRock Inc. | 29,024 | $130,027 | 0.00% |
| Citadel Advisors | 16,900 | $75,712 | 0.00% |
| Citadel Advisors | 36,247 | $162,387 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 13,400 | $60,032 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 22,200 | $99,456 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 69,790 | $312,659 | 0.00% |
| JPMORGAN CHASE & CO | 6 | $27 | 0.00% |
| Renaissance Technologies | 47,600 | $213 | 0.00% |
External links
This page lists GAIN THERAPEUTICS INC's shareholders in Q2 2023. To view GAIN THERAPEUTICS INC's shareholder history, click here.